MEG3 expression inhibits ovarian cancer proliferation through modulation of miR-885-5p
Jan. 31, 2024
About 75% of patients with ovarian cancer are diagnosed with advanced disease. It is hence of high importance to explore reliable biomarkers and their mechanisms during pathology. Growing evidence exists regarding long noncoding RNAs (lncRNAs) as regulatory factors in several cellular processes.